A rifamycin inactivating phosphotransferase family shared by environmental and pathogenic bacteria

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 19, 2014, Pages 7102-7107

  Spanogiannopoulos, Peter ^a   Waglechner, Nicholas ^a   Koteva, Kalinka ^a   Wright, Gerard D ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Drug inactivation; Gene regulation; Phosphorylation; Silent resistome

Indexed keywords

PHOSPHOTRANSFERASE; RIFAMYCIN;

ACTINOBACTERIA; ADENOSINE DIPHOSPHATE RIBOSYLATION; ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS CEREUS; BACTERIAL GENOME; BACTERIAL VIRULENCE; CONTROLLED STUDY; ENZYME ASSAY; ENZYME INACTIVATION; GENE CONTROL; GENE EXPRESSION ASSAY; HETEROLOGOUS EXPRESSION; IN VITRO STUDY; INVERTED REPEAT; LISTERIA MONOCYTOGENES; NONHUMAN; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN FAMILY;

DRUG INACTIVATION; GENE REGULATION; PHOSPHORYLATION; SILENT RESISTOME;

ACTINOBACTERIA; ANTI-BACTERIAL AGENTS; BACILLUS CEREUS; BACTERIAL PROTEINS; BASE SEQUENCE; CONSERVED SEQUENCE; DRUG DESIGN; DRUG RESISTANCE, BACTERIAL; LISTERIA MONOCYTOGENES; MOLECULAR SEQUENCE DATA; PHOSPHOTRANSFERASES; RIFAMYCINS; SOIL MICROBIOLOGY; STREPTOMYCETACEAE;

EID: 84900493268     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1402358111     Document Type: Article

References (46)

1. Fischbach MA, Walsh CT (2009) Antibiotics for emerging pathogens. Science 325(5944): 1089-1093.
2. Cooper MA, Shlaes D (2011) Fix the antibiotics pipeline. Nature 472(7341):32.
3. Bérdy J (2012) Thoughts and facts about antibiotics: Where we are now and where we are heading. J Antibiot (Tokyo) 65(8):441.
4. D'Costa VM, et al. (2011) Antibiotic resistance is ancient. Nature 477(7365):457-461.
5. D'Costa VM, McGrann KM, Hughes DW, Wright GD (2006) Sampling the antibiotic resistome. Science 311(5759):374-377.
6. Bhullar K, et al. (2012) Antibiotic resistance is prevalent in an isolated cave micro-biome. PLoS ONE 7(4):e34953.
7. Benveniste R, Davies J (1973) Aminoglycoside antibiotic-inactivating enzymes in ac-tinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria. Proc Natl Acad Sci USA 70(8):2276-2280.
8. Marshall CG, Broadhead G, Leskiw BK, Wright GD (1997) D-Ala-D-Ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the entero-coccal vancomycin-resistance ligases VanA and VanB. Proc Natl Acad Sci USA 94(12): 6480-6483.
9. Forsberg KJ, et al. (2012) The shared antibiotic resistome of soil bacteria and human pathogens. Science 337(6098):1107-1111.
10. Wright GD (2007) The antibiotic resistome: The nexus of chemical and genetic diversity. Nat Rev Microbiol 5(3):175-186.
11. Sensi P, Margalith P, Timbal MT (1959) Rifomycin, a new antibiotic; preliminary report. Farmaco Sci 14(2):146-147.
12. Aristoff PA, Garcia GA, Kirchhoff PD, Hollis Showalter HD (2010) Rifamycins-obstacles and opportunities. Tuberculosis (Edinb) 90(2):94-118.
13. Campbell EA, et al. (2001) Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell 104(6):901-912.
14. Huang DB, DuPont HL (2005) Rifaximin-A novel antimicrobial for enteric infections. J Infect 50(2):97-106.
15. Cremonini F, Lembo A (2012) Rifaximin for the treatment of irritable bowel syndrome. Expert Opin Pharmacother 13(3):433-440.
16. Rothstein DM, van Duzer J, Sternlicht A, Gilman SC (2007) Rifalazil and other ben-zoxazinorifamycins in the treatment of chlamydia-based persistent infections. Arch Pharm (Weinheim) 340(10):517-529.
17. Tupin A, et al. (2010) Resistance to rifampicin: At the crossroads between ecological, genomic and medical concerns. Int J Antimicrob Agents 35(6):519-523.
18. Ramaswamy S, Musser JM (1998) Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 79(1):3-29.
19. Floss HG, Yu TW (2005) Rifamycin-mode of action, resistance, and biosynthesis. Chem Rev 105(2):621-632.
20. Andersen SJ, Quan S, Gowan B, Dabbs ER (1997) Monooxygenase-like sequence of a Rhodococcus equi gene conferring increased resistance to rifampin by inactivating this antibiotic. Antimicrob Agents Chemother 41(1):218-221.
21. Hoshino Y, et al. (2010) Monooxygenation of rifampicin catalyzed by the rox gene product of Nocardia farcinica: Structure elucidation, gene identification and role in drug resistance. J Antibiot (Tokyo) 63(1):23-28.
22. Yazawa K, Mikami Y, Maeda A, Morisaki N, Iwasaki S (1994) Phosphorylative in-activation of rifampicin by Nocardia otitidiscaviarum. J Antimicrob Chemother 33(6): 1127-1135.
23. Spanogiannopoulos P, Thaker M, Koteva K, Waglechner N, Wright GD (2012) Characterization of a rifampin-inactivating glycosyltransferase from a screen of environmental actinomycetes. Antimicrob Agents Chemother 56(10):5061-5069.
24. Quan S, Venter H, Dabbs ER (1997) Ribosylative inactivation of rifampin by Mycobacterium smegmatis is a principal contributor to its low susceptibility to this antibiotic. Antimicrob Agents Chemother 41(11):2456-2460.
25. Altschul SF, et al. (1997) Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25(17):3389-3402.
26. Morar M, Wright GD (2010) The genomic enzymology of antibiotic resistance. Annu Rev Genet 44:25-51.
27. Cooper RA, Kornberg HL (1967) The mechanism of the phosphoenolpyruvate syn-thase reaction. Biochim Biophys Acta 141(1):211-213.
28. Singleton MR, Dillingham MS, Wigley DB (2007) Structure and mechanism of helicases and nucleic acid translocases. Annu Rev Biochem 76:23-50.
29. Narayanan CS, Dubnau D (1985) Evidence for the translational attenuation model: Ribosome-binding studies and structural analysis with an in vitro run-off transcript of ermC. Nucleic Acids Res 13(20):7307-7326.
30. Alexieva Z, Duvall EJ, Ambulos NP, Jr., Kim UJ, Lovett PS (1988) Chloramphenicol induction of cat-86 requires ribosome stalling at a specific site in the leader. Proc Natl Acad Sci USA 85(9):3057-3061.
31. Narindrasorasak S, Bridger WA (1977) Phosphoenolypyruvate synthetase of Escher-ichia coli: Molecular weight, subunit composition, and identification of phosphohis-tidine in phosphoenzyme intermediate. J Biol Chem 252(10):3121-3127.
32. Marchler-Bauer A, et al. (2013) CDD: Conserved domains and protein three-dimensional structure. Nucleic Acids Res 41(Database issue):D348-D352.
33. Geer LY, Domrachev M, Lipman DJ, Bryant SH (2002) CDART: Protein homology by domain architecture. Genome Res 12(10):1619-1623.
34. Dabbs ER, et al. (1995) Rifampicin inactivation by Bacillus species. J Antibiot (Tokyo) 48(8):815-819.
35. Dey A, Chatterji D (2012) Tracing the variation in physiological response to rifampicin across the microbial spectrum. J Bacteriol Virol 42(2):87-100.
36. Vogler AJ, et al. (2002) Molecular analysis of rifampin resistance in Bacillus anthracis and Bacillus cereus. Antimicrob Agents Chemother 46(2):511-513.
37. Hawkins AE, Bortolussi R, Issekutz AC (1984) In vitro and in vivo activity of various antibiotics against Listeria monocytogenes type 4b. Clin Invest Med 7(4):335-341.
38. Hillen W, Berens C (1994) Mechanisms underlying expression of Tn10 encoded tet-racycline resistance. Annu Rev Microbiol 48:345-369.
39. Llarrull LI, Fisher JF, Mobashery S (2009) Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge. Antimicrob Agents Chemother 53(10):4051-4063.
40. Dantas G, Sommer MO (2012) Context matters-The complex interplay between re-sistome genotypes and resistance phenotypes. Curr Opin Microbiol 15(5):577-582.
41. Torres-Cortés G, et al. (2011) Characterization of novel antibiotic resistance genes identified by functional metagenomics on soil samples. Environ Microbiol 13(4): 1101-1114.
42. Pehrsson EC, Forsberg KJ, Gibson MK, Ahmadi S, Dantas G (2013) Novel resistance functions uncovered using functional metagenomic investigations of resistance reservoirs. Front Microbiol 4(145):1-11.
43. McGarvey KM, Queitsch K, Fields S (2012) Wide variation in antibiotic resistance proteins identified by functional metagenomic screening of a soil DNA library. Appl Environ Microbiol 78(6):1708-1714.
44. Arlet G, et al. (2001) Plasmid-mediated rifampin resistance encoded by an arr-2-like gene cassette in Klebsiella pneumoniae producing an ACC-1 class C beta-lactamase. Antimicrob Agents Chemother 45(10):2971-2972.
45. Tribuddharat C, Fennewald M (1999) Integron-mediated rifampin resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 43(4):960-962.
46. Combrink KD, et al. (2007) New C25 carbamate rifamycin derivatives are resistant to inactivation by ADP-ribosyl transferases. Bioorg Med Chem Lett 17(2):522-526.